Skip to main content

Paired Ends: Jan 27, 2009

Premium

Allan Bombard has become chief medical officer of Sequenom, a new position, the company said this week. He will oversee Sequenom’s clinical and medical affairs, including clinical strategy, operations, and clinical advocacy.

Prior to joining Sequenom, Bombard was CEO of Lenetix Medical Laboratory. He holds an MD from the George Washington University School of Medicine and Health Sciences, an MBA from the University of San Diego, and a BA from Colgate University.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.